Search Within

Diane Lauren Reidy

Formats
  1. Meeting Abstract (149)
  2. Journal Article (122)
  3. Review (7)
  4. Book Section (4)
  5. Correspondence (3)
  6. Guidelines (3)
  7. Miscellaneous (3)
  8. Editorial (2)
  9. Conference Paper (1)
Groups
  1. Center for Pancreatic Cancer Research (294)
  2. Department of Medicine (294)
  3. Gastrointestinal Oncology Service (294)
  4. Solid Tumor Oncology Division (294)
  5. Survivorship Research (92)
  6. Weinberg Fellows (92)

More Groups

People
  1. Nitya Raj (82)
  2. Leonard Saltz (81)
  3. Andrea Cercek Hanjis (48)
  4. Marinela Capanu (42)
  5. Neil Segal (42)
  6. Zsofia Stadler (37)

More People

Years
  1. 2025 (3)
  2. 2024 (11)
  3. 2023 (12)
  4. 2022 (26)
  5. 2021 (26)
  6. 2020 (21)

More Years

Publications
  1. Journal of Clinical Oncology (88)
  2. Pancreas (43)
  3. Annals of Surgical Oncology (10)
  4. Journal of Vascular and Interventional Radiology (8)
  5. Journal of Nuclear Medicine (7)
  6. Annals of Oncology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (99)
  2. Lippincott Williams & Wilkins (48)
  3. Springer (23)
  4. Elsevier Inc. (20)
  5. Oxford University Press (18)
  6. Wiley Blackwell (11)

More Publishers

Results (294)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors
    Journal Article

    Abuzakhm, S. M.; Sukrithan, V.; Fruth, B.; Qin, R.; Strosberg, J.; Hobday, T. J.; Semrad, T.; Reidy-Lagunes, D.; Kindler, H. L.; Kim, G. P.; more...
    Endocrine-Related Cancer (2023)

    Fulltext@MSK | Save
  • Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas
    Journal Article

    Raj, N.; Chan, J. A.; Wang, S. J.; Aggarwal, R. R.; Calabrese, S.; DeMore, A.; Fong, L.; Grabowsky, J.; Hope, T. A.; Kolli, K. P.; more...
    British Journal of Cancer (2023)

    Fulltext@MSK | Save
  • Urinary neuroendocrine neoplasms treated in the “modern era”: A multicenter retrospective review
    Journal Article

    Le, B. K.; McGarrah, P.; Paciorek, A.; Mohamed, A.; Apolo, A. B.; Chan, D. L.; Reidy-Lagunes, D.; Hauser, H.; Rivero, J. D.; Whitman, J.; more...
    Clinical Genitourinary Cancer (2023)

    Fulltext@MSK | Save
  • Interim analysis of a prospective validation of 2 blood-based genomic assessments (PPQ and NETest) to determine the clinical efficacy of (177)Lu-DOTATATE in neuroendocrine tumors
    Journal Article

    Bodei, L.; Raj, N.; Do, R. K.; Mauguen, A.; Krebs, S.; Reidy-Lagunes, D.; Schöder, H.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Genetic profiling analysis design of well-differentiated aggressive grade 2 and 3 gastroenteropancreatic neuroendocrine tumors in the phase III randomized controlled COMPOSE trial
    Meeting Abstract

    Halfdanarson, T. R.; Capdevila, J.; Halperin, D. M.; Herrmann, K.; Kong, G.; Leyden, S.; Mailman, J.; Reidy-Lagunes, D.; Srirajaskanthan, R.; Erdö, M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Next-generation sequencing (NGS) of circulating cell-free DNA (cfDNA) in advanced pancreatic neuroendocrine neoplasms (PanNENs)
    Meeting Abstract

    Cowzer, D.; Shah, R. H.; Punn, S.; Fiedler, L.; DeMore, A.; Chou, J. F.; Capanu, M.; Berger, M. F.; Reidy-Lagunes, D.; Raj, N. P.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Characterizing the clinico-genomic landscape and outcomes of KRAS G12C mutated pancreas cancer
    Meeting Abstract

    Keane, F.; Park, W.; Varghese, A.; Balogun, F.; Yu, K.; El Dika, I.; Khalil, D.; Kelsen, D. P.; Reidy-Lagunes, D.; Ku, G. Y.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • COMPOSE: Pivotal phase III trial to compare 177Lu-edotreotide with best standard of care for well-differentiated aggressive grade 2 and grade 3 gastroenteropancreatic neuroendocrine tumours
    Meeting Abstract

    Halfdanarson, T. R.; Halperin, D.; Reidy-Lagunes, D.; Kong, G.; Mailman, J.; Herrmann, K.; Sri Rajaskanthan, R.; Leyden, S.; Capdevila Castillon, J.; Sierras, C.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Association between remote monitoring and acute care visits in high-risk patients initiating intravenous antineoplastic therapy
    Journal Article

    Daly, B.; Nicholas, K. J.; Flynn, J.; Panageas, K. S.; Silva, N.; Duck, E.; Zervoudakis, A.; Holland, J.; Salvaggio, R.; Begue, A.; more...
    JCO Oncology Practice (2022)

    Fulltext@MSK | Save
  • A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: Final analysis of efficacy and evaluation of MGMT (ECOG-ACRIN E2211)
    Meeting Abstract

    Kunz, P. L.; Graham, N.; Catalano, P. J.; Nimeiri, H.; Fisher, G. A.; Longacre, T. A.; Suarez, C. J.; Rubin, D.; Yao, J. C.; Kulke, M. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save